Navigation Links
Will the plague pathogen become resistant to antibiotics?

A small piece of DNA that helps bacteria commonly found in US meat and poultry resist several antibiotics has also been found in the plague bacillus Yersinia pestis, gene sequence researchers report.

The ability to resist many of the antibiotics used against plague has been found so far in only a single case of the disease in Madagascar. But because the same ability is present in other kinds of bacteria from a broad range of livestock, antibiotic resistance could potentially spread to other Y. pestis and also other bacterial pathogens. In a paper published March 21 in the new journal PLoS ONE, the authors say this possibility "represents a significant public health concern."

Genetic ability to disable antibiotics, including multidrug resistance (MDR) sequences, is carried on plasmids, small circles of DNA that are passed easily between bacteria. In this study, the same MDR plasmids found in the Y. pestis from Madagascar were also present in bacteria such as Salmonella and Escherichia coli found in retail samples of beef, pork, chicken, and turkey from several US states.

"What we've done is revealed a mechanism for the acquisition of multidrug resistance in Y. pestis. Obviously, this is an event that might have serious human health consequences. But the sequencing work we've done has given us a way to monitor this plasmid in future," says senior author Jacques Ravel of The Institute for Genomic Research (TIGR) in Rockville, MD.

"The fact that we found a plasmid usually found in Salmonella in Y. pestis is a big problem. It also raises a question about how this happened, how it went from one to the other. But that's a question we cannot answer in this paper," Ravel notes. He urges a new monitoring program to track MDR in Y. pestis.

MDR Salmonella and E. coli have been found in droppings from wild geese, raising the possibility that wild animals might be able to spread MDR far beyond the livestock where it originated, Rav
'"/>

Source:Public Library of Science


Page: 1 2

Related biology news :

1. Wake Forest scientists find new combination vaccine effective against plague
2. Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine
3. Novel plague virulence factor identified
4. Plant-derived vaccines safeguard against deadly plague
5. Study illuminates how the plague bacteria causes disease
6. Researchers develop rapid diagnostic tool for pathogen identification
7. A new study examines how shared pathogens affect host populations
8. New lab technique identifies high levels of pathogens in therapy pool
9. Researchers uncover sequence of major rice pathogen
10. Edible bivalves as a source of human pathogens: signals between vibrios and the bivalve host.
11. Tagging pathogens with synthetic DNA barcodes

Post Your Comments:
(Date:12/2/2009)...arette smoking and alcohol consumption before head...atient,s future risk of death, according to publis...milar effect among those who continued these habit...rs are counseled to quit smoking; despite this, ma... to smoke even after their cancer diagnosis, incre...
(Date:12/2/2009)...xposure to secondhand smoke for a prolonged period...k of breast cancer, even in women who never smoked...her exposure to side-stream smoke could increase r...aid Peggy Reynolds, Ph.D., senior research scienti...eley office. "While no single epidemiologic study ...
(Date:12/2/2009)... beef, peanut butter, and other foods have done mo...ood safety. They also are quietly fueling a boom i...ing new food safety regulations. That,s the topic ...f Chemical & Engineering News , (C&EN) ACS, weekl...Kemsley and Senior Correspondent Marc Reisch point...
Breaking Biology News(10 mins):Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Oncothyreon announces appointment of Douglas E Williams Ph D to board of directors 14352 1Oncothyreon announces appointment of Douglas E Williams Ph D to board of directors 14352 2Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs 5220 1Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs 5220 2Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs 5220 3Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs 5220 4Facilitation Payments Seen as Problematic by Many Companies 5215 1Facilitation Payments Seen as Problematic by Many Companies 5215 2Facilitation Payments Seen as Problematic by Many Companies 5215 3Facilitation Payments Seen as Problematic by Many Companies 5215 4
...ectious Diseases (NAID), one of the National Insti...versity of Washington (UW) to use systems biology ...e virus-host interactions and cellular response ne...se of acute respiratory virus infection. , This n...ze, UW professor of microbiology and associate dir...
... body,s cells normally auto-destruct may play a ro...rch published online in the journal Apoptosis a...programmed cell death. , Doctors know that geneti...cts nearly everyone older than 60, as well as many...genes are known to play a role in congenital deafn...
...uence , Both natural and human-induced influence...r relative roles and regional impacts are still un...point to increasing human-generated greenhouse gas...of global surface warming after 1967, while some e...ccounts for as much as 69 percent of warming seen ...
Other Biology News:NIAID funds studies of how SARS and bird flu evade antiviral responses 2Genes that control cell death fingered in age-related hearing loss 2Genes that control cell death fingered in age-related hearing loss 3AGU journal highlights -- Oct. 16, 2008 2AGU journal highlights -- Oct. 16, 2008 3AGU journal highlights -- Oct. 16, 2008 4AGU journal highlights -- Oct. 16, 2008 5AGU journal highlights -- Oct. 16, 2008 6AGU journal highlights -- Oct. 16, 2008 7
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire/ ...search report is available in its catalogue: ,,...pe: Market dynamics and the changing healthcare an...linker.com/p0165658/Emerging-Clinical-Trial-Locati...ing-healthcare-and-regulatory-environment.html ,...
(Date:12/1/2009)... , , Former Majority Leader Richard ...Science, Medicine, Biotech Communities for "Best ... JERSEY CITY, N.J., Dec. 1 /PRNewswire-USNewswire/... in biopharmaceuticals, research, medicine and tec...er to discuss the importance of medical innovation...
(Date:12/1/2009)... , , SPRINGFIELD, Ill., Dec. 1 /PRNews...), is proud to announce that it was recently award...e Awards event on Nov. 13 in New York City. The CL...e and innovation in the healthcare advertising ind...of the world,s most recognized awards competitions...
(Date:12/1/2009)... , EpiVax, Inc. today ann...he (SIX: RO, ROG; OTCQX: RHHBY) aimed at evaluatin... which could potentially reduce detrimental immune...Roche-EpiVax collaboration, the EpiVax Tregitope t... immunogenicity of protein therapeutics. , ...
Breaking Biology Technology:Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3
... that every company wanted to avoid: The Vapor Lis...nd then publisher of PC Letter, the List counted t..., years) between the time a software product was a.... , ,At a time when dozens of new companies were s...orm, the list was Stewart,s way of calling softwar...
...eak" in Iraq, Matt Storms is ready to continue his...ious columns covered due diligence and corporate c...ll Business Innovation Research (SBIR) and Small B...k Matt for his service, and we thank him for the f...Once you complete your due diligence and corporat...
...lecommunications Professionals of Wisconsin is con... , a networking and business support organization ...rganization said the partnership "reflects the inc...ons sector and the information technology sector a...every sector of the regional, national and world e...
Other Biology Technology:Is Beta the new Vapor? 2Is Beta the new Vapor? 3Is Beta the new Vapor? 4Raising capital through placement agents 2Raising capital through placement agents 3Raising capital through placement agents 4Accelerate Madison to merge with Telecommunications Professionals 2
Feline IL-2 ELISpot Kit from R&D Systems
FluoSpheres® biotin-labeled microspheres, 1.0 µm, yellow-green fluorescent (505/515) *1% solids* from Molecular Probes (Invitrogen)
Anti-Potassium Channel, TASK (TWIK-Related Acid Sensitive, TASK-1, cTBAK, Kcnk3) Polyclonal Antibody, Unconjugated from CHEMICON
Rat Anti-Kinase Suppressor Of Ras Monoclonal Antibody, Unconjugated, Clone MINT/1/4 from GeneTex
Biology Products: